(Q38018268)

27 August 2017

title

Gut hormones and leptin: impact on energy control and changes after bariatric surgery--what the future holds (English)

1 reference

27 August 2017

0 references

Carel le Roux

0 references

Konstantinos Michalakis

series ordinal

1 reference

27 August 2017

language of work or name

1 reference

1 October 2012

1 reference

27 August 2017

1 reference

27 August 2017

1 reference

27 August 2017

1 reference

27 August 2017

page(s)

1648-1657

1 reference

Current knowledge in the neurophysiologic modulation of obesity

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Regulation of adipokine secretion by n-3 fatty acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Entrainment of the diurnal rhythm of plasma leptin to meal timing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Soluble leptin receptor and leptin are associated with baseline adiposity and metabolic risk factors, and predict adiposity, metabolic syndrome, and glucose levels at 2-year follow-up: the Cyprus Metabolism Prospective Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Effects of leptin and adiponectin on pancreatic β-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Integration of hormonal and nutrient signals that regulate leptin synthesis and secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Intracellular signalling. Key enzyme in leptin-induced anorexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Hypothalamic regulation of energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Hormonal control of the neuropeptide Y system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Role of leptin in the activation of immune cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Gut hormones and appetite control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Human distribution and release of a putative new gut hormone, peptide YY

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Gut hormone PYY(3-36) physiologically inhibits food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Energy homeostasis and gastrointestinal endocrine differentiation do not require the anorectic hormone peptide YY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Plasma ghrelin and gastric pacing in morbidly obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Ghrelin induces adiposity in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

A role for ghrelin in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Differential Responses of Circulating Ghrelin to High-Fat or High-Carbohydrate Meal in Healthy Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Role of the duodenum and macronutrient type in ghrelin regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Nutrition and L and K-enteroendocrine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Peripheral oxyntomodulin reduces food intake and body weight gain in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Effects of meal size and composition on incretin, alpha-cell, and beta-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Inhibition of gastric inhibitory polypeptide signaling prevents obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

On the physiology of GIP and GLP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Changes in gut hormones after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Glucagon-like peptide-1: a potent regulator of food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

A role for glucagon-like peptide-1 in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

A role for the gut-to-brain GLP-1-dependent axis in the control of metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Comparison of Glucostatic Parameters After Hypocaloric Diet or Bariatric Surgery and Equivalent Weight Loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Insulin resistance, leptin and TNF-alpha system in morbidly obese women after gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Postprandial changes in gut regulatory peptides in gastric bypass patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Preliminary report: homeostasis model assessment of insulin resistance, an indicator of insulin resistance, is strongly related to serum insulin: practical data presentation and the mathematical basis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Pharmacological profile of lixisenatide: A new GLP-1 receptor agonist for the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

A new glucagon and GLP-1 co-agonist eliminates obesity in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Antagonism of ghrelin receptor reduces food intake and body weight gain in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Long-term results of bariatric restrictive procedures: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Soluble Leptin Receptor Represents the Main Leptin Binding Activity in Human Blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Plasma Osteopontin Increases After Bariatric Surgery and Correlates with Markers of Bone Turnover But Not with Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

Effects of weekly administration of pegylated recombinant human OB protein on appetite profile and energy metabolism in obese men.

21 January 2018

1 reference

12 December 2020

Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.

1 reference

12 December 2020

Effects of PYY[3-36] in rodent models of diabetes and obesity

1 reference

12 December 2020

Oxyntomodulin suppresses appetite and reduces food intake in humans

1 reference

12 December 2020

Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity

1 reference

12 December 2020

Effect of peptide YY on gastric, pancreatic, and biliary function in humans.

1 reference

12 December 2020

Proghrelin peptides: Desacyl ghrelin is a powerful inhibitor of acylated ghrelin, likely to impair physiological effects of acyl ghrelin but not of obestatin A study of pancreatic polypeptide secretion from mouse islets

1 reference

12 December 2020

Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans.

1 reference

12 December 2020

Relation between circulating leptin concentrations and appetite during a prolonged, moderate energy deficit in women

1 reference

12 December 2020

The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction

1 reference

12 December 2020

Peripheral administration of PYY(3-36) produces conditioned taste aversion in mice

1 reference

12 December 2020

Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy

1 reference

12 December 2020

Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy

1 reference

12 December 2020

Enhanced dietary fat clearance in postobese women.

1 reference

12 December 2020

Gastric inhibitory polypeptide (GIP) and insulin in obesity: Increased response to stimulation and defective feedback control of serum levels

1 reference

12 December 2020

Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis

1 reference

12 December 2020

Energy homeostasis, obesity and eating disorders: recent advances in endocrinology

1 reference

12 December 2020

Early Changes in Ghrelin following Roux-en-Y Gastric Bypass: Influence of Vagal Nerve Functionality?

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamic effects of oral GLP-1 and PYY3-36: a proof-of-concept study in healthy subjects

1 reference

12 December 2020

Subcutaneous oxyntomodulin analogue administration reduces body weight in lean and obese rodents.

1 reference

12 December 2020

10.1007/S11695-012-0698-9

Identifiers

DOI

1 reference

release_2zxipuzckna45dye27elzp76ei

27 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2zxipuzckna45dye27elzp76ei

24 November 2022

mapped directly with Wikidata item

1 reference